User profiles for Derjung M. Tarn

Derjung Mimi Tarn

UCLA Department of Family Medicine
Verified email at mednet.ucla.edu
Cited by 2518

Physician communication when prescribing new medications

DM Tarn, J Heritage, DA Paterniti… - Archives of internal …, 2006 - jamanetwork.com
Background Communication about taking a new medication is critical to proper use of drug
therapy and to patient adherence. Despite ample evidence that medications are not taken as …

A qualitative study of primary care physicians' experiences with telemedicine during COVID-19

…, YB Anaya, KJ Shih, DM Tarn - The Journal of the …, 2021 - Am Board Family Med
Background: Primary care practices rapidly adopted telemedicine visits because of the
COVID-19 pandemic, but information on physician perspectives about these visits is lacking. …

A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising

DL Frosch, D Grande, DM Tarn… - American Journal of …, 2010 - ajph.aphapublications.org
Direct-to-consumer advertising (DTCA) of prescription drugs has remained controversial
since regulations were liberalized by the Food and Drug Administration in 1997. We reviewed …

Reducing parental trauma and stress in neonatal intensive care: systematic review and meta-analysis of hospital interventions

A Sabnis, S Fojo, SS Nayak, E Lopez, DM Tarn… - Journal of …, 2019 - nature.com
Objective To classify NICU interventions for parental distress and quantify their effectiveness.
Study design We systematically reviewed controlled studies published before 2017 …

Older patient, physician and pharmacist perspectives about community pharmacists' roles

DM Tarn, DA Paterniti, NS Wenger… - … Journal of Pharmacy …, 2012 - academic.oup.com
Derjung M Tarn , Derjung M Tarn … They're fine with all the medications, so they come and
say, “Oh, is it going to interact with the medications that I'm taking?” . . . we are the only people …

How much time does it take to prescribe a new medication?

DM Tarn, DA Paterniti, RL Kravitz, J Heritage… - Patient education and …, 2008 - Elsevier
OBJECTIVE: To measure the length of time spent discussing all aspects of new prescriptions
and guideline-recommended aspects of counseling, and to evaluate factors associated …

Trust in one's physician: the role of ethnic match, autonomy, acculturation, and religiosity among Japanese and Japanese Americans

DM Tarn, LS Meredith, M Kagawa-Singer… - The Annals of Family …, 2005 - Annals Family Med
PURPOSE Trust is a cornerstone of the physician-patient relationship. We investigated the
relation of patient characteristics, religiosity, acculturation, physician ethnicity, and insurance-…

Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives

DM Tarn, DA Paterniti, BR Williams… - Journal of the …, 2009 - Wiley Online Library
OBJECTIVES: To investigate older patient, pharmacist, and physician perspectives about
what information is essential to impart to patients receiving new medication prescriptions and …

Repair with collagen tubules linked with brain-derived neurotrophic factor and ciliary neurotrophic factor in a rat sciatic nerve injury model

…, GM Coan, ET Cheng, C Niell, DM Tarn… - … –Head & Neck …, 1998 - jamanetwork.com
Objective To determine if brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic
factor (CNTF) can be successfully delivered to transected and repaired peripheral nerves by …

[HTML][HTML] Implementation of Physician Orders for Life Sustaining Treatment in nursing homes in California: evaluation of a novel statewide dissemination mechanism

…, A Diamant, K Lorenz, V Gonzalez, DM Tarn - Journal of General …, 2013 - Springer
BACKGROUND Implementing Physician Orders for Life Sustaining Treatment (POLST) forms
aims to improve communication of life-sustaining treatment preferences across care venues…